Related Experiment Video
Updated: Mar 8, 2026

05:52
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.6K
29 Year Old Man with Multiple Sclerosis and Schizophrenia: A Case Report
Nahid Noorani1, Fateme Hadi2, Hamid Reza Ahmadkhaniha3
1M.D., Psychiatrist, Tehran, Iran.
Electronic Physician
|February 7, 2017
Summary
This case report details a young adult male diagnosed with multiple sclerosis (MS) and schizophrenia. Effective treatment involved a combination of antipsychotics and antidepressants, managing both neurological and psychiatric symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Case Study
Background:
- Multiple sclerosis (MS) is a common neurological disorder, with neuropsychiatric symptoms frequently observed alongside neurological deficits.
- This case highlights the complex interplay between MS and psychiatric conditions, specifically schizophrenia in a young adult male with a history of obsessive-compulsive disorder (OCD).
Observation:
- A 29-year-old male with a history of obsessive-compulsive disorder (OCD) was diagnosed with MS.
- The patient subsequently developed auditory hallucinations and delusions, initially suspected as schizophrenia.
- Psychotic symptoms were refractory to irregular treatment with Haloperidol and Perphenazine, co-occurring with active MS relapses.
Findings:
- The patient's psychotic symptoms and MS were eventually controlled with a combination of Aripiprazole, Risperidone, and Sertraline.
- The case suggests a simultaneous onset of MS and schizophrenia in this patient.
- Crucially, there appeared to be no direct correlation between the MS relapses and the psychotic episodes.
Implications:
- This unique case highlights the complex interplay between MS and severe psychiatric disorders like schizophrenia.
- The distinct clinical course and management suggest that MS and schizophrenia may arise independently or concurrently.
- Understanding such presentations can aid clinicians in diagnosing and managing patients with co-occurring MS and neuropsychiatric conditions.

